Viewing Study NCT00193232


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:16 PM
Study NCT ID: NCT00193232
Status: COMPLETED
Last Update Posted: 2010-07-28
First Post: 2005-09-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
Sponsor: SCRI Development Innovations, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module